Fig. 4From: Using Omniscan-Loaded Nanoparticles as a Tumor-Targeted MRI Contrast Agent in Oral Squamous Cell Carcinoma by Gelatinase-Stimuli Strategya, b Axial MRI images and line chart of tumor-to-background ratio of xenograft model of human OSCC at the indicated tumor positions acquired with a T1-weighted sequence. The error bars represent the standard deviations of three separate measurementsBack to article page